ArticleScientometrics2021
Publishing volumes in major databases related to Covid-19.
Article in Scientometrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
52 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The long COVID research literature.Frontiers in research metrics and analytics · 2023Pooled it
- Beyond what meets the eye: unveiling dynamics of compliance with preventive measures in the COVID-19 era.BMC public health · 2026Article
- Resilience and Recalibration of Bibliometric Indicators in Neurosciences and Neuropharmacology Journals After COVID-19: A Longitudinal Rate of Change Analysis Using Mixed-Effects Models.Current neuropharmacology · 2026Article
- Scientometric analysis of research productivity in clinical pharmacy and practice: a 12-year review at a Middle Eastern university.Journal of pharmaceutical policy and practice · 2025Article
- Evidence-informed decision-making in public health in Canada: a qualitative exploration.JBI evidence implementation · 2025Article
- Facilitating knowledge transfer to policy makers and front-line workers during a pandemic: Implementation, impact and lessons learned.Health information and libraries journal · 2024Article
- Reimagining How We Synthesize Information to Impact Clinical Care, Policy, and Research Priorities in Real Time: Examples and Lessons Learned from COVID-19.Journal of general internal medicine · 2024Article
- Imitation versus serendipity in ranking dynamics.Royal Society open science · 2024Article
- A qualitative study of leaders' experiences of handling challenges and changes induced by the COVID-19 pandemic in rural nursing homes and homecare services.BMC health services research · 2024Article
- Metacell-based differential expression analysis identifies cell type specific temporal gene response programs in COVID-19 patient PBMCs.NPJ systems biology and applications · 2024Article
- Effect of the COVID-19 pandemic on the pediatric infectious disease landscape.European journal of pediatrics · 2024Review
- Article
- The impact of COVID-19 on the interpretation of psycho-oncological support trial results: a quasi-experimental approach using the data from the new form of care "Integrated cross-sectoral psycho-oncology (nFC-isPO)".BMC health services research · 2023Article
- Expedited editorial decision in COVID-19 pandemic.Journal of informetrics · 2023Article
- Transparency and reporting characteristics of COVID-19 randomized controlled trials.BMC medicine · 2022Article
- A Survey on Methodological Issues of Clinical Research Studies Reviewed by Independent Ethic Committees during the COVID-19 Pandemic in Italy.International journal of environmental research and public health · 2022Article
- Demonstrating an approach for evaluating synthetic geospatial and temporal epidemiologic data utility: results from analyzing >1.8 million SARS-CoV-2 tests in the United States National COVID Cohort Collaborative (N3C).Journal of the American Medical Informatics Association : JAMIA · 2022Article
- The Perception of Evidence-based Dentistry among Dental Professionals in Saudi Arabia during COVID-19 Pandemic.Journal of pharmacy & bioallied sciences · 2022Article
- Distribution of COVID-19 government support and its consequences for firm liquidity and solvency.Structural change and economic dynamics · 2022Article
- Coronavirus disease 2019 (COVID-19) research agenda for healthcare epidemiology.Infection control and hospital epidemiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The SARS-CoV-2 virus, which causes Covid-19, induced a global pandemic for which an effective cure, either in the form of a drug or vaccine, has yet to be discovered. In the few brief months that the world has known Covid-19, there has been an unprecedented volume of papers published related to this disease, either in a bid to find solutions, or to discuss applied or related aspects. Data from Clarivate Analytics' Web of Science, and Elsevier's Scopus, which do not index preprints, were assessed. Our estimates indicate that 23,634 unique documents, 9960 of which were in common to both databases, were published between January 1 and June 30, 2020. Publications include research articles, letters, editorials, notes and reviews. As one example, amongst the 21,542 documents in Scopus, 47.6% were research articles, 22.4% were letters, and the rest were reviews, editorials, notes and other. Based on both databases, the top three countries, ranked by volume of published papers, are the USA, China, and Italy while
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.